2007
DOI: 10.1124/mol.107.038018
|View full text |Cite
|
Sign up to set email alerts
|

Antithrombotic Effect of a Protein-Type I Class Snake Venom Metalloproteinase, Kistomin, Is Mediated by Affecting Glycoprotein Ib-von Willebrand Factor Interaction

Abstract: Binding of von Willebrand factor (vWF) to platelet glycoprotein (GP) Ib-IX-V mediates platelet activation in the early stage of thrombus formation. Kistomin, a snake venom metalloproteinase (SVMP) purified from venom of Calloselasma rhodostoma, has been shown to inhibit vWF-induced platelet aggregation. However, its action mechanism, structure-function relationship, and in vivo antithrombotic effects are still largely unknown. In the present study, cDNA encoding kistomin precursor was cloned and revealed that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
24
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
5
2
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(27 citation statements)
references
References 25 publications
2
24
0
1
Order By: Relevance
“…Indeed, the Mascot hits found where procoagulant activity was observed revealed the presence of both these toxin types, along with C-type lectins and an L-amino acid oxidase (Table 2). The SVSP identified (“Thrombin-like enzyme ancrod-2”; SC, 53%) has previously been shown to be fibrinogenolytic (51), while the literature relating to the SVMPs detected (“Snake venom metalloproteinase kistomin” and “Zinc metalloproteinase/disintegrin” SC, 33% and 27%, respectively) suggests they predominately exert anticoagulant activities, including interfering with platelet aggregation and promoting haemorrhage (52, 53). It is therefore possible that these toxins are co-eluting with procoagulant components, although given that many SVMPs are multi-functional proteins that can exert procoagulant bioactivities (54), they may be contributing to the functional effect observed here despite these activities not previously being reported.…”
Section: Resultsmentioning
confidence: 99%
“…Indeed, the Mascot hits found where procoagulant activity was observed revealed the presence of both these toxin types, along with C-type lectins and an L-amino acid oxidase (Table 2). The SVSP identified (“Thrombin-like enzyme ancrod-2”; SC, 53%) has previously been shown to be fibrinogenolytic (51), while the literature relating to the SVMPs detected (“Snake venom metalloproteinase kistomin” and “Zinc metalloproteinase/disintegrin” SC, 33% and 27%, respectively) suggests they predominately exert anticoagulant activities, including interfering with platelet aggregation and promoting haemorrhage (52, 53). It is therefore possible that these toxins are co-eluting with procoagulant components, although given that many SVMPs are multi-functional proteins that can exert procoagulant bioactivities (54), they may be contributing to the functional effect observed here despite these activities not previously being reported.…”
Section: Resultsmentioning
confidence: 99%
“…Intact GPIb plays critical role in the extent and rate of platelet aggregation stimulated by low concentrations of thrombin [80]. Kistomin cleaves platelet GPIbα at two distinct sites releasing 45- and 130-kDa soluble fragments and specifically inhibits von Willebrand factor- (vWF-) induced platelet aggregation [81]. Kistomin also cleaves vWF resulting in the formation of low-molecular-mass multimers.…”
Section: Platelet Aggregation Antagonistsmentioning
confidence: 99%
“…Kistomin also cleaves vWF resulting in the formation of low-molecular-mass multimers. It inhibits GPIbα agonist-induced platelet aggregation, and prolongs the occlusion time in mesenteric microvessels and tail-bleeding time in mice [81]. Kistomin also inhibits platelet aggregation induced by collagen and convulxin (Glycoprotein VI (GPVI) [82].…”
Section: Platelet Aggregation Antagonistsmentioning
confidence: 99%
“…A maioria dos estudos com a peçonha de C. rhodostoma, está relacionado com a purificação e caracterização de proteínas que interferem na hemostasia sanguínea, como por exemplo, a rhodosthoxin que é uma hemorragina com alto potencial proteolítico, hemorrágico e indutor de edema e a kistomin, que é uma metaloprotease da classe P-I, com efeito antitrombolítico in vivo (PONNUDURAI et al, 1993;HSU et al, 2007).…”
Section: L-aminoácido Oxidase De Calloselasma Rhodostoma (Cr-laao)unclassified